期刊
THROMBOSIS JOURNAL
卷 17, 期 -, 页码 -出版社
BMC
DOI: 10.1186/s12959-019-0198-4
关键词
Anti-microthrombotic therapy; C5b-9 (membrane attack complex [MAC]); Disseminated intravascular coagulation (DIC; ill-founded DIC); Disseminated intravascular microthrombosis (DIT); Endotheliopathy; Microthrombogenesis; Multiorgan dysfunction syndrome (MODS); Therapeutic plasma exchange (TPE); TTP-like syndrome; Unusually large von Willebrand factor multimers (ULVWF); Vascular microthrombotic disease (VMTD)
In addition to protective immune response, sepsis is characterized by destructive endothelial response of the host, leading to endotheliopathy and its molecular dysfunction. Complement activation generates membrane attack complex (MAC). MAC causes channel formation to the cell membrane of pathogen, leading to death of microorganisms. In the host, MAC also may induce channel formation to innocent bystander endothelial cells (ECs) and ECs cannot be protected. This provokes endotheliopathy, which activates two independent molecular pathways: inflammatory and microthrombotic. Activated inflammatory pathway promotes the release of inflammatory cytokines and triggers inflammation. Activated microthrombotic pathway mediates platelet activation and exocytosis of unusually large von Willebrand factor multimers (ULVWF) from ECs and initiates microthrombogenesis. Excessively released ULVWF become anchored to ECs as long elongated strings and recruit activated platelets to assemble platelet-ULVWF complexes and form microthrombi. These microthrombi strings trigger disseminated intravascular microthrombosis (DIT), which is the underlying pathology of endotheliopathy-associated vascular microthrombotic disease (EA-VMTD). Sepsis-induced endotheliopathy promotes inflammation and DIT. Inflammation produces inflammatory response and DIT orchestrates consumptive thrombocytopenia, microangiopathic hemolytic anemia, and multiorgan dysfunction syndrome (MODS). Systemic inflammatory response syndrome (SIRS) is a combined phenotype of inflammation and endotheliopathy-associated (EA)-VMTD. Successful therapeutic design for sepsis can be achieved by counteracting the pathologic microthrombogenesis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据